Skip to main content

Maui Health Now Offering Monoclonal Antibody Treatment

Maui Health has partnered with Kaiser Permanente to offer outpatient monoclonal antibody treatment to Maui residents.

Monoclonal antibody treatment (mAb) is a form of immunotherapy to fight viral infections and has been shown to reduce the risk of severe illness and hospitalization from COVID-19 by as much as 70%.

If you recently tested positive for COVID-19 and are at high risk for severe illness, you may qualify for monoclonal antibody (mAb) treatment. To qualify, patients must be:

  1. Within ten (10) days of start of mild to moderate symptoms, AND
  2. At high risk for severe illness, including BMI greater than 25, chronic kidney disease,
    diabetes, immunocompromised disorders, and other chronic health conditions.

The new treatment center operates seven days a week from 8:00 a.m. to 4:30 p.m. at Kaiser Permanente’s Maui Lani Medical Office with assistance from Federal Emergency Management Agency (FEMA) nurses provided by Maui Health.

To learn how to schedule an appointment and for a complete list of qualified risk factors and criteria, please visit